Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
Five new cases of blood clots likely linked to AstraZeneca But evidence indicates the benefits of the vaccine still outweigh the risks, according to the TGA.
Blood clots up to 10 times more common with COVID than vaccines: Study Research has identified the various risks of people experiencing cerebral venous thrombosis, which has been linked to the AstraZeneca vaccine.
‘No change’ in risk profile with second blood clot case linked to AstraZeneca Two cases of clotting in 700,000 administered doses does not indicate an increased level of risk, experts have said.
AstraZeneca blood clot link increases importance of Novavax But with clinical trials progressing slowly, uncertainty remains over when Australia will access the 51 million doses of its third vaccine candidate.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
Do children’s healthy blood vessels protect them from severe COVID-19? The virus is now known to target endothelial cells present in every blood vessel – and that may open up new treatment options.
Working towards a cure for Parkinson’s The Government is making a major investment to improve quality of life for people with Parkinson’s disease – and ultimately find a cure.
New care standard highlights GPs’ importance in prevention of blood clot deaths GPs can play a key role in prevention of deaths from venous thromboembolism after hospitalisation, which is a much more serious problem than many people may realise.